Testimony heats up in latest talc-mesothelioma trial

31 Aug 2018 by under Legal

talc justice 100x100 Testimony heats up in latest talc mesothelioma trialOn the fifth day of trial in a case brought by plaintiff Carolyn Weirick accusing of knowingly selling talcum powder products that contained asbestos and contributed to her terminal cancer, Weirick’s attorneys called materials science and electron microscopy expert William Longo to the stand. He told a California jury that he examined a sample of talc taken from a bottle of Johnson’s Baby Powder used by Carolyn Weirick and found asbestos fibers.

Using what he called a “generally accepted” scientific technique, Longo determined that there were about 6.3 million asbestos fibers in Weirick’s bottle of talcum powder when it was full. Asbestos is a mineral with microscopic fibers that can enter the body through inhalation or ingestion and cause serious illnesses including chronic lung disease, lung cancer, and mesothelioma, a rare form of cancer that develops in the lining of the lungs, abdomen and other internal organs. Mesothelioma is also known as asbestos cancer.

Longo also testified that he reviewed dozens of Johnson & Johnson internal testing documents that revealed there was asbestos in the company’s talc-containing products.

Longo has testified for plaintiffs in several cases alleging Johnson & Johnson’s products contain asbestos and contributed to cancer diagnoses. He was an expert witness in the case of Stephen Lanzo III who was awarded $117 million by a New Jersey jury after it found the company’s talc was tainted with asbestos and contributed to Lanzo’s mesothelioma.

Longo also testified at the trial of 22 women who were awarded $4.69 billion based on claims the asbestos in Johnson & Johnson’s talcum powders caused their ovarian cancer.

Weirick filed her lawsuit against Johnson & Johnson and its talc supplier in April 2017. She claimed that her near-daily use of Johnson’s baby powder and Shower to Shower body powder contributed to her deadly disease.

Source: Law360

Comments are closed.